Cellectis S.A. Cash and Cash Equivalents 2011-2026 | CLLS

Annual Cash and Cash Equivalents Cellectis S.A.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
61.5 M	143 M	137 M	93.2 M	186 M	241 M	341 M	452 M	256 M	255 M	342 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
452 M	61.5 M	228 M

Quarterly Cash and Cash Equivalents Cellectis S.A.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	186 M	-	248 M	-	241 M	-	261 M	-	341 M	-	397 M	-	452 M	-	-	-	256 M	-	-	-	255 M	-	-	-	342 M	-	-	-	136 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
452 M	136 M	283 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
AgeX Therapeutics AGE	3.06 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	4.76 B	-	-	$ 866 M	China
Akero Therapeutics AKRO	340 M	-	-	$ 3.67 B	USA
Midatech Pharma plc MTP	8.53 M	-	-18.52 %	$ 27.3 M	Britain
AlloVir ALVR	98.1 M	-	4.14 %	$ 49.1 M	USA
Aptorum Group Limited APM	3.5 M	$ 0.88	-1.69 %	$ 6.47 M	China
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	81.8 M	-	2.54 %	$ 160 B	France
Aquestive Therapeutics AQST	121 M	$ 4.1	1.23 %	$ 438 M	USA
ACADIA Pharmaceuticals ACAD	320 M	$ 22.45	1.13 %	$ 3.72 B	USA
Athira Pharma ATHA	69.3 M	-	-	$ 269 M	USA
Applied Molecular Transport AMTI	61.1 M	-	-	$ 10.1 M	USA
Ayala Pharmaceuticals AYLA	2.41 M	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	5.71 B	-	-	$ 96.9 B	Britain
Atreca BCEL	30.8 M	-	-11.76 %	$ 5.79 M	USA
Berkeley Lights BLI	86.5 M	-	-7.31 %	$ 87 M	USA
Calithera Biosciences CALA	59.5 M	-	-10.95 %	$ 876 K	USA
Advaxis ADXS	4.88 M	-	-9.65 %	$ 45.9 M	USA
CymaBay Therapeutics CBAY	207 M	-	-	$ 3.45 B	USA
ChemoCentryx CCXI	50 M	-	-	$ 3.74 B	USA
Cerus Corporation CERS	20 M	$ 2.03	5.73 %	$ 387 M	USA
Caladrius Biosciences CLBS	16.2 M	-	-16.75 %	$ 25.8 M	USA
Checkmate Pharmaceuticals CMPI	50.7 M	-	-	$ 231 M	USA
Kazia Therapeutics Limited KZIA	7.36 M	$ 13.64	9.82 %	$ 1.81 B	Australia
Aeterna Zentaris AEZS	7.31 M	-	5.93 %	$ 314 M	Canada
BioNTech SE BNTX	7.68 B	$ 103.45	1.85 %	$ 27.2 B	Germany
Brainstorm Cell Therapeutics BCLI	29 K	-	-2.5 %	$ 5.88 M	USA
Aeglea BioTherapeutics AGLE	85.7 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	46.4 M	-	-	$ 26.5 M	USA
Deciphera Pharmaceuticals DCPH	83.5 M	-	-	$ 2.18 B	USA
AIkido Pharma AIKI	34 M	-	1.93 %	$ 17.4 M	USA
Innate Pharma S.A. IPHA	28.1 M	$ 1.44	-3.36 %	$ 235 M	France
Dynavax Technologies Corporation DVAX	95.9 M	-	-	$ 2.02 B	USA
Akouos AKUS	122 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	66.4 M	-	-	$ 28.6 M	USA
Editas Medicine EDIT	147 M	$ 3.0	6.38 %	$ 266 M	USA
Edesa Biotech EDSA	1 M	$ 18.27	14.94 %	$ 58.4 M	USA
Can-Fite BioPharma Ltd. CANF	8.27 M	$ 3.19	6.69 %	$ 5.25 M	Israel
Eiger BioPharmaceuticals EIGR	25.4 M	-	-9.21 %	$ 2.55 M	USA
Eloxx Pharmaceuticals ELOX	19.2 M	-	-5.68 %	$ 8.28 M	USA
CureVac N.V. CVAC	811 M	-	-	$ 867 M	Germany
Ampio Pharmaceuticals AMPE	4.09 M	-	-11.43 %	$ 502 K	USA
Applied Therapeutics APLT	49.9 M	-	-	$ 8.42 M	USA
Aptose Biosciences APTO	935 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	56.2 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	53.7 M	-	-13.39 %	$ 1.45 M	USA